期刊文献+

Survivin表位肽诱导CTL免疫学效应及杀瘤效应研究 被引量:2

Study on the immune and anti-tumor responses of CTL cells generated from Survivin-derived epitopes
下载PDF
导出
摘要 目的:探讨Survivin HLA-A2限制性细胞毒性T淋巴细胞(CTL)表位SV20-28、SV23-31、SV88-96、负载DC诱导CTL免疫学效应和杀瘤活性。方法:从外周血中分离PBMC诱导DC,用Survivin高亲和性SV20-28、中等亲和性SV23-31及低亲和性表位肽SV88-96负载DC并诱导CTL;用酶联免疫斑点法(ELISPOT),检测CTL细胞IFN-γ的分泌情况;用乳酸脱氢酶(LDH)释放法检测其对靶细胞的杀伤作用。结果:Survivin高亲和性表位SV20-28和中等亲和力表位SV23-31负载DC诱导的CTL能产生分泌IFN-γ细胞,在ELISPOT试验中效靶比为1∶1时产生的斑点数分别为183.42±16.07、76.08±8.42,显著高于阴性对照组斑点数,P<0.05;而低亲和力表位SV88-96诱导的CTL未能产生明显的IFN-γ分泌细胞。高亲和力及中等亲和力表位肽诱导的CTL能以MHCⅠ限制方式杀伤Survivin阳性细胞,在效靶比为50∶1、25∶1、12.5∶1时的杀伤率分别为(62.40±5.16)%、(44.0±2.32)%、(26.53±1.07)%和(33.42±4.76)%、(25.16±2.64)%、(15.83±1.57)%,显著高于阴性对照组:(5.59±0.16)%、(4.76.0±0.32)%、(2.93±0.07)%;而低亲和力表位肽SV88-96诱导的免疫细胞对靶细胞没有明显的杀伤作用。结论:Survivin表位肽负载DC可有效诱导出CTL,Survivin表位肽SV20-28、SV23-31可有效诱导CTL产生免疫反应,并能以MHCⅠ限制方式杀伤Survivin阳性细胞。 Objective:To investigate immune and anti-tumor responses of CTL cells generated from DC loaded with HLA-restricted Survivin-derived peptide.Methods:The ability of producing IFN-γ and killing tumor cell of CTL induced by using high-affinity peptide SV20-28,intermediate-affinity peptide SV23-31 and low-affinity peptide SV88-96 respectively were measured by using ELISPOT method and LDH release assay.Results:Survivin-specific CTLs could be generated from the high-affinity survivin peptide of SV20-28-and the intermediate-affinity survivin pepticd SV23-31-loaded dendritic cells.The CTLs secreted IFN-γ.The number of the spots for CTL/SV20-28 cells and CTL/SV23-31 cells was 183.42±16.07 and 76.08±8.42 respectively,markedly higher than that of negative control with P〈0.05,while no obvious immuno-responses were observed for CTL/SV88-96cells.Survivin-specific CTL induced from high-affinity and intermediate-affinity survivin peptide SV20-28 and SV23-31 could kill survivin-positive cancerous cells in MHC class I-restricted fashion.The specific cytolytic rates of the CTLs were (62.40±5.16)%,(44.0±2.32)% and (26.53±1.07)% at effector to target ratio of 50 to 1,25 to 1 and 12.5 to 1 when induced by DCs loading SV20-28,and the rates for SV23-31 were (33.42±4.76)% and (25.16±2.64)% and (15.83±1.57)% at the same effector to target ratio.Conclusion:Survivin-derived peptides SV20-28 and SV23-31 can efficiently induce survivin-specific CTLs which can recognize and kill survivin positive cancerous cells in MHC class I-restricted fashion.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2010年第8期693-698,共6页 Chinese Journal of Immunology
基金 福建省科技发展计划重点项目(No.20008I0012)
关键词 表位 SURVIVIN 细胞毒性T淋巴细胞 Epitope Survivin CTL
  • 相关文献

参考文献10

  • 1Purcell A W,McCluskey J,Rossjohn J.More than one reason to rethink the use of peptides in vaccine design[J].Nature,2007;6(5):404-414.
  • 2陈明水,陈强,李洁羽,周智锋,陈淑萍,叶韵斌.Survivin HLA-A2^+高亲和性CTL表位的预测及鉴定[J].中国肿瘤生物治疗杂志,2009,16(3):227-231. 被引量:3
  • 3张秀敏,隋延仿,司少艳,胡沛臻,黄杨,葛伟,李侠,马斌.联合表位肽诱导HLA-A2^+人PBMC产生抗原特异性CTL及杀伤活性研究[J].现代肿瘤医学,2006,14(8):913-916. 被引量:2
  • 4Allen S M,Florell S R,Hanks A N et al.Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression[J].Cancer Res,2003;63(3):567-572.
  • 5Williams N S,Gaynor R B,Scoggin S et al.Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.[J] Clin Cancer Res,2003;9(3):931-946.
  • 6Velculescu V E,Madden S L,Zhang L et al.Analysis of human transcriptomes.[J] Nat Genet,1999;23(4):387-388.
  • 7应学翔,邹强,徐永华,王恩忠,王红鹰,胡轶红,倪泉兴.负载Her-2多肽的DCIK细胞对乳腺癌细胞杀伤作用研究[J].分子细胞生物学报,2007,40(4):193-198. 被引量:8
  • 8Kono K,Takahashi A,Sugai H et al.Dendritic cells pulsed with HER-2/neu-derived peptides can induce specific T-cell responses in patients with gastric cancer[J].Clin Cancer Res,2002;8(11):3394-3400.
  • 9Schmitz M,Diestelkoetter P,Weigle B et al.Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides[J].Cancer Res,2000;60(17):4845-4849.
  • 10Andersen M H,Pedersen L φ,Capeller B et al.Spontaneous cytotoxic T-cell responses against Survivin-derived MHC class I-restricted T-cell epitopes in Situ as well as ex vivo in cancer patients[J].Cancer Research,2001;61(16):5964-5968.

二级参考文献38

  • 1Li F.Survivin study:what is the nextwave[J]? J Cell Physiol,2003,197(1):8-29.
  • 2Kessler JH,Melief CJM.Identification of T-cell epitopes for cancerimmunotherapy[J].Leukemia,2007,21(3):1859-1874.
  • 3Seki N,Brooks AD,Carter CR,et al.Tumor-specific CTL kill murine renal cancer cellsusing both perforin and Fas ligand-mediated lysis in vitro,but cause tumor regression invivo in the absence of perforin[J].J Immunol,2002,168(7):3484-3892.
  • 4Tourdot S,Scardino A,Saloustrou E,et al.A general strategy to enhance immunogenicity oflow-affinity HLA-A2.1-associated peptides:implication in the identification of cryptictumor epitopes[J].Eur J Immunol,2000,30:3411-3421.
  • 5Lanzavecchia A.Identifying strategies for immuneintervention[J].Science,1993,260(511):937-944.
  • 6Bhasin M,Raghava GP.A hybrid approach for predicting promiscuous MHC class Ⅰrestricted T cell epitopes[J].J Biosci,2007,32(1):31-42.
  • 7Parker KC,Bednarek MA,Coligan JE.Scheme for ranking potential HLA-A2 binding peptidesbased on independent binding of individual peptide side-chains[J].JImmunol,1994,152(1):163-175.
  • 8Rammensee H,Bachmann J,Emmerich NP,et al.SYFPEITHY database for MHC ligands and peptidemotifs[J].Immunogenetics,1999,50(1):213-219.
  • 9Andersen MH,Becker JC,Straten P.Regulators of apoptosis:suitable targets forimmunetherapy of cancer[J].Nature,2005,4(5):399-409.
  • 10Duffy MJ,O'Donovan N,Brennan DJ,et al.Survivin:a promising tumor biomarker[J].J CancerLett,2007,249(1):49-60.

共引文献10

同被引文献40

  • 1孙玉静,隋延仿,吴道澄,葛伟,叶菁,张秀敏.肿瘤特异性抗原纳米乳剂的制备及抗肿瘤免疫效应[J].中国药理学通报,2005,21(3):288-291. 被引量:11
  • 2王美亮,朱勇,王九平,刘京梅,方亮,金伯泉.汉滩病毒核蛋白T细胞表位的鉴定及其特异性T细胞应答规律的初步探讨[J].细胞与分子免疫学杂志,2005,21(6):704-706. 被引量:2
  • 3Wang Y, WhittaU T, McGowan E, et al. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells [J]. J Immunol, 2005, 174(6) : 3306-3316.
  • 4Barlow DJ, EDwards MS, Thornton JM. Continuous and discontinuous protein antigenic determinants[J]. Nature,1986, 322(6081): 747-748.
  • 5Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences[J]. Proc Natl Acad Sci USA, 1981, 78(6): 3824-3828.
  • 6来鲁花.蛋白质的结构预测和分子设计[M].北京:北京大学出版社.1993:49.
  • 7Tsche H. Modern methods in protein and nucleic acid research [M]. New York: Walter de Gruger Berlin, 1990: 1231.
  • 8Welling GW, Weijer WJ, van der Zee R, et al. Prediction of sequential antigenic regions in proteins[J]. FEBS Lett, 1985, 188(2): 215-218.
  • 9Karplus PA, Schulz GE. Prediction of chain flexibility in proteins [J]. Naturwissenschaften,1985, 72(4): 212-213.
  • 10Gershoni JM, Stern B, Denisova G. Combinatorial libraries, epitope structure and the prediction of protein conformations [J]. Immunol Today, 1997, 18(3): 108-110.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部